Openfund

CORDIS · EATRIS-Plus

Consolidating the capacities of EATRIS-ERIC for Personalised Medicine

Код
EATRIS-Plus
Програма
H2020
Процедура
INFRADEV-03-2018-2019
Статус
CLOSED
Период
01.01.2020 – 31.12.2023
Обща стойност (целият консорциум)4 999 024 €
Принос на ЕС (целият консорциум)4 999 023 €
Принос на ЕС за българските участници65 625 €

Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис

Участници

ОрганизацииРоляДържаваБезвъзмездна помощ
EATRIS ERICкоординаторNL972 508 €
UNIVERZITA PALACKEHO V OLOMOUCIучастникCZ571 000 €
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUMучастникNL432 260 €
UPPSALA UNIVERSITETучастникSE392 362 €
HELSINGIN YLIOPISTOучастникFI368 761 €
LUXEMBOURG INSTITUTE OF HEALTHучастникLU313 292 €
SERVICIO MADRILENO DE SALUDучастникES276 120 €
FORUM DES PATIENTS EUROPEENSучастникBE195 134 €
UNIVERSITETET I OSLOучастникNO160 375 €
INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IPучастникPT149 375 €
BIOCAT LA FUNDACIO BIOREGIO DE CATALUNYAучастникES144 720 €
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESучастникFR143 412 €
UNIVERZA V LJUBLJANIучастникSI137 750 €
ISTITUTO SUPERIORE DI SANITAучастникIT133 344 €
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLINучастникIE106 210 €
KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)участникDE101 250 €
RIGAS STRADINA UNIVERSITATEучастникLV93 438 €
SOFIA UNIVERSITY ST KLIMENT OHRIDSKIучастникBG65 625 €
SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTETучастникHR45 394 €
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCAучастникES43 055 €
ITA-SUOMEN YLIOPISTOучастникFI40 024 €
OSPEDALE SAN RAFFAELE SRLтрета странаIT0 €
EUROPEAN AIDS TREATMENT GROUP EVтрета странаDE0 €
Masarykova univerzitaтрета странаCZ0 €

Описание

In the first five years of operations, EATRIS has shown strong proof of concept of the value of the services portfolio, with users ranging from academia, SMEs, large pharma, to biotech and research funding organisations. The overarching aim of EATRIS-Plus is to support the long-term sustainability (LTS) of EATRIS by delivering innovative scientific tools to the research community, strengthening the infrastructure’s financial model and reinforcing EATRIS leadership in the European Research Area (ERA), particularly in the field of Personalised Medicine (PM) research and development. Specific objectives are: (i) To consolidate EATRIS capacities in the field of PM to better serve academia and industry and augment the number of EATRIS Innovation Hubs with large pharma; (ii) To further strengthen the LTS of EATRIS financial model; (iii) To drive patient empowerment through active involvement in the infrastructure’s operations; (iv) To expand strategic partnerships with Research Infrastructures and other relevant stakeholders. The proposal relies on a scientific and technological programme combined with capacity-building activities across 16 EU countries, with the support of two umbrella organisations representing patient organisations and SMEs. EATRIS-Plus will help pooling and exploiting the translational academic capacities of the infrastructure in omic technologies to enable researchers to better address the scientific and societal challenge of PM. Additionally, the coordination office and 13 existing national nodes of the infrastructure will participate in implementing joint outreach, training, industry engagement and international collaboration activities to further build national capacity, increase users’ trust and strengthen EATRIS and the ERA global scientific leadership.

Официални данни · CORDIS · синхронизирано 17.10.2026 10:16 · официален запис · Лиценз: © European Union, CC BY 4.0 (Commission reuse policy).